Mantilla-Rojas, C.; Velasquez, F.C.; Morton, J.E.; Clemente, L.C.; Parra, E.R.; Torres-Cabala, C.; Sevick-Muraca, E.M.
Enhanced T-Cell Priming and Improved Anti-Tumor Immunity through Lymphatic Delivery of Checkpoint Blockade Immunotherapy. Cancers 2022, 14, 1823.
https://doi.org/10.3390/cancers14071823
AMA Style
Mantilla-Rojas C, Velasquez FC, Morton JE, Clemente LC, Parra ER, Torres-Cabala C, Sevick-Muraca EM.
Enhanced T-Cell Priming and Improved Anti-Tumor Immunity through Lymphatic Delivery of Checkpoint Blockade Immunotherapy. Cancers. 2022; 14(7):1823.
https://doi.org/10.3390/cancers14071823
Chicago/Turabian Style
Mantilla-Rojas, Carolina, Fred C. Velasquez, Janelle E. Morton, Leticia C. Clemente, Edwin R. Parra, Carlos Torres-Cabala, and Eva M. Sevick-Muraca.
2022. "Enhanced T-Cell Priming and Improved Anti-Tumor Immunity through Lymphatic Delivery of Checkpoint Blockade Immunotherapy" Cancers 14, no. 7: 1823.
https://doi.org/10.3390/cancers14071823
APA Style
Mantilla-Rojas, C., Velasquez, F. C., Morton, J. E., Clemente, L. C., Parra, E. R., Torres-Cabala, C., & Sevick-Muraca, E. M.
(2022). Enhanced T-Cell Priming and Improved Anti-Tumor Immunity through Lymphatic Delivery of Checkpoint Blockade Immunotherapy. Cancers, 14(7), 1823.
https://doi.org/10.3390/cancers14071823